IL43652A - 1,3-disubstituted-imidazolidinones - Google Patents
1,3-disubstituted-imidazolidinonesInfo
- Publication number
- IL43652A IL43652A IL43652A IL4365273A IL43652A IL 43652 A IL43652 A IL 43652A IL 43652 A IL43652 A IL 43652A IL 4365273 A IL4365273 A IL 4365273A IL 43652 A IL43652 A IL 43652A
- Authority
- IL
- Israel
- Prior art keywords
- group
- chloro
- compound
- phenyl
- imidazolidin
- Prior art date
Links
- -1 1,3-disubstituted-imidazolidinones Chemical class 0.000 title claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 50
- 239000000203 mixture Substances 0.000 claims description 45
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 14
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 229940091173 hydantoin Drugs 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 125000004043 oxo group Chemical group O=* 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 239000011737 fluorine Substances 0.000 claims description 5
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- LZTUXYRRAUHBJV-UHFFFAOYSA-N 2-oxo-3-phenylimidazolidine-1-sulfonamide Chemical compound O=C1N(S(=O)(=O)N)CCN1C1=CC=CC=C1 LZTUXYRRAUHBJV-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 240000000662 Anethum graveolens Species 0.000 claims 1
- 150000005690 diesters Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 106
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 54
- 239000000047 product Substances 0.000 description 37
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 22
- 229940093499 ethyl acetate Drugs 0.000 description 22
- 235000019439 ethyl acetate Nutrition 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 229930040373 Paraformaldehyde Natural products 0.000 description 17
- 229920002866 paraformaldehyde Polymers 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 8
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 7
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 5
- 230000035939 shock Effects 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- NJWPBUCTYQFQRT-UHFFFAOYSA-N 3-chloro-4-(4-methyl-5-oxo-3-phenylimidazolidin-1-yl)benzenesulfonamide Chemical compound O=C1C(C)N(C=2C=CC=CC=2)CN1C1=CC=C(S(N)(=O)=O)C=C1Cl NJWPBUCTYQFQRT-UHFFFAOYSA-N 0.000 description 2
- ACMFVPDOFPFKJE-UHFFFAOYSA-N 3-chloro-4-[3-(3-methylphenyl)-5-oxoimidazolidin-1-yl]benzenesulfonamide Chemical compound CC1=CC=CC(N2CC(=O)N(C2)C=2C(=CC(=CC=2)S(N)(=O)=O)Cl)=C1 ACMFVPDOFPFKJE-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 2
- 229960001413 acetanilide Drugs 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical class O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 2
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- QAXUFCWQLCDYHE-UHFFFAOYSA-N n-(2-chloro-4-sulfamoylphenyl)-2-(cyclohexylamino)acetamide Chemical compound ClC1=CC(S(=O)(=O)N)=CC=C1NC(=O)CNC1CCCCC1 QAXUFCWQLCDYHE-UHFFFAOYSA-N 0.000 description 2
- SURZZUVRYGBSTA-UHFFFAOYSA-N n-phenyl-2-(4-sulfamoylanilino)acetamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1NCC(=O)NC1=CC=CC=C1 SURZZUVRYGBSTA-UHFFFAOYSA-N 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- UTWMIRWUUYTUCG-UHFFFAOYSA-N 1-cyclohexyl-3-(4-nitrophenyl)imidazolidin-4-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1C(=O)CN(C2CCCCC2)C1 UTWMIRWUUYTUCG-UHFFFAOYSA-N 0.000 description 1
- HXNHNGHBCAZTBR-UHFFFAOYSA-N 2-(3-chloroanilino)-n-(2-chloro-4-sulfamoylphenyl)acetamide Chemical compound ClC1=CC(S(=O)(=O)N)=CC=C1NC(=O)CNC1=CC=CC(Cl)=C1 HXNHNGHBCAZTBR-UHFFFAOYSA-N 0.000 description 1
- TWVKWOVUABWHEQ-UHFFFAOYSA-N 2-anilino-n-(4-sulfamoylphenyl)acetamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1NC(=O)CNC1=CC=CC=C1 TWVKWOVUABWHEQ-UHFFFAOYSA-N 0.000 description 1
- YOCIJWAHRAJQFT-UHFFFAOYSA-N 2-bromo-2-methylpropanoyl bromide Chemical compound CC(C)(Br)C(Br)=O YOCIJWAHRAJQFT-UHFFFAOYSA-N 0.000 description 1
- CLUZBEDAQBTAHF-UHFFFAOYSA-N 2-bromo-n-(2-chloro-4-sulfamoylphenyl)propanamide Chemical compound CC(Br)C(=O)NC1=CC=C(S(N)(=O)=O)C=C1Cl CLUZBEDAQBTAHF-UHFFFAOYSA-N 0.000 description 1
- IPYRGOWSZFWQRP-UHFFFAOYSA-N 2-chloro-n-(4-nitrophenyl)acetamide;4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1.[O-][N+](=O)C1=CC=C(NC(=O)CCl)C=C1 IPYRGOWSZFWQRP-UHFFFAOYSA-N 0.000 description 1
- WBDDNKFSVVIFOG-UHFFFAOYSA-N 2-chloro-n-(4-sulfamoylphenyl)acetamide Chemical compound NS(=O)(=O)C1=CC=C(NC(=O)CCl)C=C1 WBDDNKFSVVIFOG-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- GJDOTZCAPARBNT-UHFFFAOYSA-N 3-chloro-4-[3-(3-methoxyphenyl)-5-oxoimidazolidin-1-yl]benzenesulfonamide Chemical compound COC1=CC=CC(N2CC(=O)N(C2)C=2C(=CC(=CC=2)S(N)(=O)=O)Cl)=C1 GJDOTZCAPARBNT-UHFFFAOYSA-N 0.000 description 1
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 1
- NIDOTDANGJJHPU-UHFFFAOYSA-N 4-amino-2-chlorobenzenesulfonamide Chemical compound NC1=CC=C(S(N)(=O)=O)C(Cl)=C1 NIDOTDANGJJHPU-UHFFFAOYSA-N 0.000 description 1
- KQEVQYJWCZRLTJ-UHFFFAOYSA-N 4-amino-3-bromobenzenesulfonamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1Br KQEVQYJWCZRLTJ-UHFFFAOYSA-N 0.000 description 1
- LFIOFZKZCDMGFG-UHFFFAOYSA-N 4-amino-3-chlorobenzenesulfonamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1Cl LFIOFZKZCDMGFG-UHFFFAOYSA-N 0.000 description 1
- CBEXIFWSJPPAND-UHFFFAOYSA-N 4-amino-3-chlorobenzenesulfonamide;2-bromo-n-(2-chloro-4-sulfamoylphenyl)propanamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1Cl.CC(Br)C(=O)NC1=CC=C(S(N)(=O)=O)C=C1Cl CBEXIFWSJPPAND-UHFFFAOYSA-N 0.000 description 1
- IGQGXIVCGKMRAM-UHFFFAOYSA-N 4-amino-3-methylbenzenesulfonamide Chemical compound CC1=CC(S(N)(=O)=O)=CC=C1N IGQGXIVCGKMRAM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100495531 Caenorhabditis elegans cgh-1 gene Proteins 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methyl-N-phenylamine Natural products CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920013631 Sulfar Polymers 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- GVONPBONFIJAHJ-UHFFFAOYSA-N imidazolidin-4-one Chemical compound O=C1CNCN1 GVONPBONFIJAHJ-UHFFFAOYSA-N 0.000 description 1
- 150000008624 imidazolidinones Chemical class 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- AIVFYFVRRCWVMJ-UHFFFAOYSA-N methyl n-[2-(cyclohexylamino)-2-oxoethyl]-n-(4-sulfamoylphenyl)carbamate Chemical compound C=1C=C(S(N)(=O)=O)C=CC=1N(C(=O)OC)CC(=O)NC1CCCCC1 AIVFYFVRRCWVMJ-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- FEVZZUSIXSRKKB-UHFFFAOYSA-N n-(2-chloro-4-sulfamoylphenyl)-2-(4-methylanilino)acetamide Chemical compound C1=CC(C)=CC=C1NCC(=O)NC1=CC=C(S(N)(=O)=O)C=C1Cl FEVZZUSIXSRKKB-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000004291 sulphur dioxide Substances 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5343772A GB1408010A (en) | 1972-11-20 | 1972-11-20 | Sulphamoylphenyl-imidazolidinones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL43652A0 IL43652A0 (en) | 1974-03-14 |
| IL43652A true IL43652A (en) | 1977-10-31 |
Family
ID=10467808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL43652A IL43652A (en) | 1972-11-20 | 1973-06-19 | 1,3-disubstituted-imidazolidinones |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3963706A (fr) |
| JP (1) | JPS541312B2 (fr) |
| AR (1) | AR211379Q (fr) |
| AT (1) | AT330766B (fr) |
| AU (1) | AU470359B2 (fr) |
| BE (1) | BE807490A (fr) |
| CA (1) | CA1021783A (fr) |
| CH (3) | CH605808A5 (fr) |
| DE (1) | DE2357591C3 (fr) |
| DK (1) | DK138645B (fr) |
| ES (1) | ES420661A1 (fr) |
| FI (1) | FI57934C (fr) |
| FR (1) | FR2206947B1 (fr) |
| GB (1) | GB1408010A (fr) |
| HU (1) | HU170143B (fr) |
| IE (1) | IE39319B1 (fr) |
| IL (1) | IL43652A (fr) |
| NL (1) | NL7315807A (fr) |
| PL (1) | PL97758B1 (fr) |
| SE (1) | SE417960B (fr) |
| ZA (1) | ZA738824B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2332542B1 (fr) | 1999-12-06 | 2015-02-11 | Geistlich Pharma AG | Utilisation de taurolidine ou de taurultame pour la fabrication d'un medicament pour traiter des tumeurs |
| CN100519525C (zh) * | 1999-12-06 | 2009-07-29 | 葛兰素集团有限公司 | 芳香砜类及其医疗用途 |
| YU52403A (sh) * | 2000-12-26 | 2006-03-03 | Dr.Reddy's Research Foundation | Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže |
| US7160912B2 (en) | 2000-12-26 | 2007-01-09 | Dr.Reddy's Laboratories Ltd. | Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them |
| US6753328B2 (en) | 2001-10-01 | 2004-06-22 | Rhode Island Hospital | Methods of inhibiting metastases |
| US20060293315A1 (en) * | 2001-12-21 | 2006-12-28 | Dr. Reddy's Laboratories Ltd. | Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1472625A (fr) * | 1965-03-31 | 1967-05-24 |
-
1972
- 1972-11-20 GB GB5343772A patent/GB1408010A/en not_active Expired
-
1973
- 1973-06-19 IL IL43652A patent/IL43652A/en unknown
- 1973-11-19 BE BE137896A patent/BE807490A/fr unknown
- 1973-11-19 ES ES420661A patent/ES420661A1/es not_active Expired
- 1973-11-19 CH CH1621173A patent/CH605808A5/xx not_active IP Right Cessation
- 1973-11-19 FR FR7341140A patent/FR2206947B1/fr not_active Expired
- 1973-11-19 IE IE2094/73A patent/IE39319B1/xx unknown
- 1973-11-19 DE DE2357591A patent/DE2357591C3/de not_active Expired
- 1973-11-19 AR AR251062A patent/AR211379Q/es unknown
- 1973-11-19 PL PL1973166622A patent/PL97758B1/pl unknown
- 1973-11-19 HU HUGE946A patent/HU170143B/hu unknown
- 1973-11-19 SE SE7315644A patent/SE417960B/xx unknown
- 1973-11-19 AU AU62660/73A patent/AU470359B2/en not_active Expired
- 1973-11-19 CH CH1601476A patent/CH605802A5/xx not_active IP Right Cessation
- 1973-11-19 CH CH1393177A patent/CH603594A5/xx not_active IP Right Cessation
- 1973-11-19 ZA ZA738824A patent/ZA738824B/xx unknown
- 1973-11-19 CA CA186,100A patent/CA1021783A/en not_active Expired
- 1973-11-19 US US05/416,854 patent/US3963706A/en not_active Expired - Lifetime
- 1973-11-19 DK DK622673AA patent/DK138645B/da not_active IP Right Cessation
- 1973-11-19 NL NL7315807A patent/NL7315807A/xx not_active Application Discontinuation
- 1973-11-19 FI FI3561/73A patent/FI57934C/fi active
- 1973-11-19 JP JP12927973A patent/JPS541312B2/ja not_active Expired
- 1973-11-19 AT AT968773A patent/AT330766B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HU170143B (fr) | 1977-04-28 |
| ZA738824B (en) | 1974-09-25 |
| FI57934B (fi) | 1980-07-31 |
| DE2357591C3 (de) | 1980-02-28 |
| IE39319L (en) | 1974-05-20 |
| FI57934C (fi) | 1980-11-10 |
| US3963706A (en) | 1976-06-15 |
| JPS541312B2 (fr) | 1979-01-23 |
| CH605802A5 (fr) | 1978-10-13 |
| DE2357591A1 (de) | 1974-05-22 |
| ES420661A1 (es) | 1976-04-01 |
| AT330766B (de) | 1976-07-26 |
| CH603594A5 (fr) | 1978-08-31 |
| JPS4993362A (fr) | 1974-09-05 |
| FR2206947B1 (fr) | 1977-10-28 |
| PL97758B1 (pl) | 1978-03-30 |
| AR211379Q (es) | 1977-12-15 |
| CH605808A5 (fr) | 1978-10-13 |
| DK138645C (fr) | 1979-03-19 |
| IE39319B1 (en) | 1978-09-13 |
| GB1408010A (en) | 1975-10-01 |
| NL7315807A (fr) | 1974-05-22 |
| FR2206947A1 (fr) | 1974-06-14 |
| SE417960B (sv) | 1981-04-27 |
| AU470359B2 (en) | 1975-05-22 |
| CA1021783A (en) | 1977-11-29 |
| ATA968773A (de) | 1975-10-15 |
| DE2357591B2 (de) | 1979-07-05 |
| BE807490A (fr) | 1974-05-20 |
| DK138645B (da) | 1978-10-09 |
| IL43652A0 (en) | 1974-03-14 |
| AU6266073A (en) | 1975-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5128358A (en) | Aryl substituted nitrogen heterocyclic antidepressants | |
| EP0247725B1 (fr) | Camp phosphodiestrerase inhibiteur antidépresseur indépendant de calcium | |
| CA1152515A (fr) | Derives de l'imidazole, production et utilisation | |
| CA1253862A (fr) | Derives de disubstitution en n,n de (2-oxo-1,2,3,5- tetrahydroimidazo-¬2,1-b|quinazolinyl)- oxyalcoylamides | |
| US4880810A (en) | Quinazolinediones and pyridopyrimidinediones | |
| JP3212758B2 (ja) | キノキサリン−２，３−（１ｈ，４ｈ）−ジオン | |
| US5294730A (en) | Calcium independent camp phosphodiesterase inhibitor antidepressant | |
| HU176842B (en) | Process for producing new n-bracket-tetrasol-5-yl-bracket closed-benzamide derivatives | |
| HU185389B (en) | Process for preparing imidazole-5-acetic acid derivatives | |
| JP3243733B2 (ja) | 新規イソキノリン誘導体 | |
| EP0081324B1 (fr) | Dérivés substitués d'imidazole avec activité pharmacologique, leur préparation et utilisation | |
| FR2705095A1 (fr) | Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| IL43652A (en) | 1,3-disubstituted-imidazolidinones | |
| US4952698A (en) | Imidazole derivatives | |
| SU610488A3 (ru) | Способ получени -фенилпирролов | |
| US3979408A (en) | 2-(Pyrrol-1-yl)amino-4,5-dihydro-1H-imidazole derivatives | |
| US3966760A (en) | 2-Substituted-5,6-dimethoxyindazoles | |
| IE42422B1 (en) | Triazolo isoindole derivatives | |
| AU606819B2 (en) | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides | |
| FI57104B (fi) | Foerfarande foer framstaellning av befruktningshindrande nya s-triatsolo(5,1-a)isokinolinderivat | |
| Vega et al. | Thiophene isosteres: synthesis and pharmacological study of 3-(azol-1-yl) thieno isothiazole-1, 1-dioxides | |
| US2397250A (en) | Compounds of the imidazolidone series and process of making them | |
| US5539114A (en) | Process for the preparation of substituted quinazoline-2,4,-diones | |
| US4067868A (en) | Production of quinazolinone compounds | |
| US3740413A (en) | 2-benzimidazolecarboxamides |